Imaging of in vitro parenteral drug precipitation

Daniel C. Evans, Michael W. Kudenov, Kimberly C. Sassenrath, Eustace L. Dereniak, Samuel H Yalkowsky

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Solid particulate matter introduced into the bloodstream as a result of parenteral drug administration can produce serious pathological conditions. Particulate matter that cannot be eliminated by pre-infusion filtration is often the result of drug precipitation that occurs when certain parenteral formulations are mixed with blood. A new device is designed to model the mixing of drug formulations with flowing blood utilizing a uniquely designed flow cell and a CCD camera to view the formulation as it is mixed with a blood surrogate in real time. The performance of the proposed device is measured using 3 commercially available parenteral formulations previously tested using a validated in vitro model.

Original languageEnglish (US)
Pages (from-to)219-223
Number of pages5
JournalInternational Journal of Pharmaceutics
Volume512
Issue number1
DOIs
StatePublished - Oct 15 2016

Fingerprint

Particulate Matter
Pharmaceutical Preparations
Equipment and Supplies
Drug Compounding
In Vitro Techniques

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Imaging of in vitro parenteral drug precipitation. / Evans, Daniel C.; Kudenov, Michael W.; Sassenrath, Kimberly C.; Dereniak, Eustace L.; Yalkowsky, Samuel H.

In: International Journal of Pharmaceutics, Vol. 512, No. 1, 15.10.2016, p. 219-223.

Research output: Contribution to journalArticle

Evans, Daniel C. ; Kudenov, Michael W. ; Sassenrath, Kimberly C. ; Dereniak, Eustace L. ; Yalkowsky, Samuel H. / Imaging of in vitro parenteral drug precipitation. In: International Journal of Pharmaceutics. 2016 ; Vol. 512, No. 1. pp. 219-223.
@article{085d767cef89478d8267af594dc40132,
title = "Imaging of in vitro parenteral drug precipitation",
abstract = "Solid particulate matter introduced into the bloodstream as a result of parenteral drug administration can produce serious pathological conditions. Particulate matter that cannot be eliminated by pre-infusion filtration is often the result of drug precipitation that occurs when certain parenteral formulations are mixed with blood. A new device is designed to model the mixing of drug formulations with flowing blood utilizing a uniquely designed flow cell and a CCD camera to view the formulation as it is mixed with a blood surrogate in real time. The performance of the proposed device is measured using 3 commercially available parenteral formulations previously tested using a validated in vitro model.",
author = "Evans, {Daniel C.} and Kudenov, {Michael W.} and Sassenrath, {Kimberly C.} and Dereniak, {Eustace L.} and Yalkowsky, {Samuel H}",
year = "2016",
month = "10",
day = "15",
doi = "10.1016/j.ijpharm.2016.08.030",
language = "English (US)",
volume = "512",
pages = "219--223",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Imaging of in vitro parenteral drug precipitation

AU - Evans, Daniel C.

AU - Kudenov, Michael W.

AU - Sassenrath, Kimberly C.

AU - Dereniak, Eustace L.

AU - Yalkowsky, Samuel H

PY - 2016/10/15

Y1 - 2016/10/15

N2 - Solid particulate matter introduced into the bloodstream as a result of parenteral drug administration can produce serious pathological conditions. Particulate matter that cannot be eliminated by pre-infusion filtration is often the result of drug precipitation that occurs when certain parenteral formulations are mixed with blood. A new device is designed to model the mixing of drug formulations with flowing blood utilizing a uniquely designed flow cell and a CCD camera to view the formulation as it is mixed with a blood surrogate in real time. The performance of the proposed device is measured using 3 commercially available parenteral formulations previously tested using a validated in vitro model.

AB - Solid particulate matter introduced into the bloodstream as a result of parenteral drug administration can produce serious pathological conditions. Particulate matter that cannot be eliminated by pre-infusion filtration is often the result of drug precipitation that occurs when certain parenteral formulations are mixed with blood. A new device is designed to model the mixing of drug formulations with flowing blood utilizing a uniquely designed flow cell and a CCD camera to view the formulation as it is mixed with a blood surrogate in real time. The performance of the proposed device is measured using 3 commercially available parenteral formulations previously tested using a validated in vitro model.

UR - http://www.scopus.com/inward/record.url?scp=84983680577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983680577&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2016.08.030

DO - 10.1016/j.ijpharm.2016.08.030

M3 - Article

C2 - 27543352

AN - SCOPUS:84983680577

VL - 512

SP - 219

EP - 223

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -